ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2026
Hypothalamic Glutamatergic/Orexinergic Neurons Attenuate Fentanyl-Induced Respiratory Depression via Medullary Pre-BöTzinger Complex Pathways.
Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Opioid-induced respiratory depression, particularly from fentanyl, is a major contributor to overdose mortality. The hypothalamus plays a modulatory role in breathing, potentially via orexinergic and glutamatergic projections to medullary respiratory centers. Here, we investigated the role of hypothalamic neurons in counteracting fentanyl-induced respiratory depression (FIRD) in male and female mice. We found that orexin (ORX) and glutamatergic (VGlut2+) neurons are distributed in dorsal hypothalamic nuclei, mainly in the lateral hypothalamus (LH) and more sparsely in the paraventricular nucleus (PVN) and send projections to the pre-Bötzinger complex (preBötC) in the medulla. Hypercapnia activated ORX neurons in the LH, but not in the PVN. Pharmacological blockade of ORX signaling with a dual ORX receptor antagonist dose-dependently suppressed respiratory activity and exacerbated FIRD. Using chemogenetics and whole-body plethysmography, we found that activation of dorsal hypothalamic neurons projecting to the preBötC increased respiratory rate and attenuated FIRD. Activation of glutamatergic neurons in either the LH or PVN stimulated ventilation; however, this effect was independent of ORX signaling. Notably, activation of LH-glutamatergic neurons successfully reduced FIRD, whereas activation of PVN glutamatergic neurons failed to attenuate FIRD. Chemogenetic activation of LH neurons projecting to the preBötC increased respiratory rate in an ORX signaling-dependent manner and was sufficient to attenuate FIRD. In contrast, activation of PVN neurons projecting to the preBötC enhanced active movements/arousal of mice but had minimal effects on respiratory parameters. Therefore, these findings suggest that LH-ORX/glutamatergic projections to the medulla drive respiratory activity that can alleviate FIRD in mice of either sex.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.